Evidence map›Paper›PMID 31108959›Full record

ReviewGenes2019

Retinal miRNA Functions in Health and Disease.

Marta Zuzic, Jesus Eduardo Rojo Arias, Stefanie Gabriele Wohl, Volker Busskamp

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Molecular therapy. Nucleic acids · 2025
    Article
  10. Article
  11. Role of miRNA in adult ocular tumorigenesis.Frontiers in molecular biosciences · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Epigenetic Switches in Retinal Homeostasis and Target for Drug Development.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Proliferative Vitreoretinopathy: A Reappraisal.Journal of clinical medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Marta ZuzicCenter for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, 01307 Dresden, Germany. marta.zuzic@tu-dresden.de.
Jesus Eduardo Rojo AriasCenter for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, 01307 Dresden, Germany. Jesus_Eduardo.Rojo_Arias@tu-dresden.de.
Stefanie Gabriele WohlDepartment of Biological and Vision Sciences, The State University of New York, College of Optometry, New York, NY 10036, USA. swohl@sunyopt.edu.ORCID 0000-0003-2559-7678
Volker BusskampCenter for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, 01307 Dresden, Germany. volker.busskamp@tu-dresden.de.ORCID 0000-0001-7517-8944
Technische Universität Dresden · DESUNY College of Optometry · US

Funding

European Research Council 678071
6 · The paper itself

Abstract

The health and function of our visual system relies on accurate gene expression. While many genetic mutations are associated with visual impairment and blindness, we are just beginning to understand the complex interplay between gene regulation and retinal pathologies. MicroRNAs (miRNAs), a class of non-coding RNAs, are important regulators of gene expression that exert their function through post-transcriptional silencing of complementary mRNA targets. According to recent transcriptomic analyses, certain miRNA species are expressed in all retinal cell types, while others are cell type-specific. As miRNAs play important roles in homeostasis, cellular function, and survival of differentiated retinal cell types, their dysregulation is associated with retinal degenerative diseases. Thus, advancing our understanding of the genetic networks modulated by miRNAs is central to harnessing their potential as therapeutic agents to overcome visual impairment. In this review, we summarize the role of distinct miRNAs in specific retinal cell types, the current knowledge on their implication in inherited retinal disorders, and their potential as therapeutic agents.

Indexed as

Cell DifferentiationEye Diseases, HereditaryGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHumansMicroRNAsPhotoreceptor Cells, VertebrateRetinaRetinal DegenerationRetinitis PigmentosaRNA, MessengerTranscriptomeMicroRNAsRNA, Messengerbipolar cellsconesmicroRNAMüller gliaphotoreceptorsretinaretinal degenerationretinal inherited disordersretinitis pigmentosarods

Identifiers

PMID31108959
PMCPMC6562649
OpenAlexW2945902503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.